Literature DB >> 27917719

Prevention and Treatment of Postoperative Endophthalmitis Using Povidone-Iodine.

Hiroyuki Shimada1, Hiroyuki Nakashizuka2, Andrzej Grzybowski3.   

Abstract

Postoperative endophthalmitis is typically caused by patient's conjunctival bacterial flora or contaminated solutions and instruments. Visual outcome is often poor in severe cases, and treatment is especially difficult when endophthalmitis is caused by multidrug resistant bacteria. Povidone-iodine is used worldwide due to its wide-spectrum antimicrobial activity, absence of resistant bacteria to povidone-iodine, and low cost. Furthermore, the effective concentration against microorganisms and safe concentration for ocular tissues have been well established. For ocular surface washing, the safe and highly bactericidal concentrations range from 0.050 to 0.500%. Repeated washing of the ocular surface with 0.250% povidone-iodine every 20-30 seconds during ophthalmic surgeries eliminates the conjunctival normal flora, minimizing the passage of bacteria into intraocular compartment, and is thus useful for the prevention of endophthalmitis. The concentration range of 0.013%-0.027% is effective for the treatment of endophthalmitis and nontoxic to intraocular tissues. In a small case series, 4 eyes with endophthalmitis were treated by vitrectomy using 0.025% povidone-iodine in Balanced Salt Solution (BSS) PLUS for vitreous irrigation. In all eyes, endophthalmitis was resolved with no ocular complications and visual acuity was improved. When performing ophthalmic surgeries, washing the ocular surface with saline containing 0.250% povidone-iodine every 20-30 seconds is safe for ocular tissues and effective for the prevention of endophthalmitis. A small case series suggested the effectiveness and safety of using irrigation solution containing 0.025% povidone-iodine in vitrectomy for the treatment of endophthalmitis, but this treatment method remains to be established. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Bacterial flora in conjunctival sac; intravitreal irrigation; ocular surface irrigation; ocular toxicity; postoperative endophthalmitis; povidone-iodine; resistant bacteria; safe concentration

Mesh:

Substances:

Year:  2017        PMID: 27917719     DOI: 10.2174/1381612822666161205105404

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  10 in total

1.  Povidone-iodine concentration and in vitro killing time of bacterial corneal ulcer isolates.

Authors:  Jagger C Koerner; Mary J George; Elizabeth A Kissam; Michael G Rosco
Journal:  Digit J Ophthalmol       Date:  2018-12-19

2.  Intraocular lens implantation and vitrectomy using 0.025% povidone-iodine in irrigation solution for bleb-related endophthalmitis.

Authors:  Yorihisa Kitagawa; Hiroyuki Shimada; Hiroyuki Nakashizuka; Takayuki Hattori; Yoshio Yamazaki
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

3.  Capsular bag irrigation using 0.025% povidone-iodine in balanced salt solution PLUS for the treatment of postoperative endophthalmitis.

Authors:  Kyuen Otani; Hiroyuki Shimada
Journal:  Int Ophthalmol       Date:  2017-10-12       Impact factor: 2.031

4.  Evaluation of Retinal Function and Pathology After Intravitreal Injection of Povidone-Iodine and Polyvinyl Alcohol-Iodine in Rabbits.

Authors:  Hiroyuki Shimada; Kimiko Kato; Kazuumi Ishida; Takanori Yamaguchi; Kei Shinoda
Journal:  Transl Vis Sci Technol       Date:  2020-04-15       Impact factor: 3.283

5.  Polyvinyl alcohol-iodine induced corneal epithelial injury in vivo and its protection by topical rebamipide treatment.

Authors:  Masamichi Fukuda; Shinsuke Shibata; Naoko Shibata; Nobuyuki Fujita; Hisanori Miyashita; Naoki Tanimura; Hidetoshi Ishida; Eri Kubo; Hiroshi Sasaki
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

6.  Topical Ocular Povidone-Iodine as an Adjunctive Preventative Practice in the Era of COVID-19.

Authors:  Terrence P O'Brien; Jesse Pelletier
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021-03-23

7.  Safety Measures for Maintaining Low Endophthalmitis Rate after Intravitreal Anti-Vascular Endothelial Growth Factor Injection before and during the COVID-19 Pandemic.

Authors:  Koji Tanaka; Hiroyuki Shimada; Ryusaburo Mori; Yorihisa Kitagawa; Hajime Onoe; Kazuki Tamura; Hiroyuki Nakashizuka
Journal:  J Clin Med       Date:  2022-02-07       Impact factor: 4.241

8.  Doctor I Have an Iodine Allergy.

Authors:  Michael W Stewart
Journal:  Ophthalmol Ther       Date:  2022-04-24

Review 9.  Evolution of and developments in simultaneous bilateral cataract surgery. Update 2020.

Authors:  Gurinder Singh; Andrzej Grzybowski
Journal:  Ann Transl Med       Date:  2020-11

10.  Bactericidal activity of three different antiseptic ophthalmic preparations as surgical prophylaxis.

Authors:  Daniele Tognetto; Marco R Pastore; Gian Marco Guerin; Giuliana Decorti; Martina Franzin; Cristina Lagatolla; Gabriella Cirigliano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-24       Impact factor: 3.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.